Global Cell Therapy And Tissue Engineering Market Size By Material (Biologically Derived, Synthetic), By Type (Cell Therapy, Tissue Engineering), By Application (Genetic Diseases, Tissue Malignancy), By Geographic Scope And Forecast

Cell Therapy And Tissue Engineering Market Size And Forecast

Cell Therapy And Tissue Engineering Market size was valued at USD 32.3 Billion in 2024 and is projected to reach USD 95.4 Billion by 2031, growing at a CAGR of 31.42% from 2024 to 2031.

Since the term “tissue engineering” was invented in 1993, the sectors of tissue engineering, cell therapy, and regenerative medicine have progressed from benchtop ideas to commercial products that are broadly used in clinics. The ability of tissue engineering processes to treat irreversible tissue damage has boosted market growth. Furthermore, an increase in demand for regenerative medicine and tissue engineering processes to cure injured tissue augments this growth. The Global Cell Therapy And Tissue Engineering Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cell Therapy And Tissue Engineering Market Definition

Cell therapy is the use of living cells to treat or potentially cure human illness or condition. Tissue engineering is a medical field that focuses on restoring, sustaining, significantly improving, or substituting damaged tissues and organs by combining scaffolds, cells, and bioactive molecules. The National Center for Biotechnology Information defines tissue engineering broadly as the integration of engineering and biology to progress the reconstruction or improve the performance of tissue function. For regenerative purposes, artificial organs, biomaterials, and cell therapies that use autologous or donor cells have been used.

Global Cell Therapy And Tissue Engineering Market Overview

The Cell Therapy And Tissue Engineering Market is expected to expand rapidly due to rising rates of chronic diseases, traffic accidents, and severe injuries, technical advances in 3D tissue engineering, and continuing tissue regeneration research. The increasing prevalence of chronic diseases, traffic accidents, and trauma injuries has been discovered to be making a contribution to the expansion in the advancement of tissue engineering remedies. The number of individuals who need bone implants is growing due to an increase in chronic disease cases, trauma cases, and an increase in average life span.

Furthermore, there is a demand for relatively inexpensive and readily available skin-replacement products, which has prompted many research groups around the world to focus on developing biomaterials for skin substitution. The engineered tissues not only close wounds but also stimulate dermal regeneration, offering a major benefit in human wound healing. The procedures are extremely expensive, posing the biggest obstacle to the global market.

Global Cell Therapy And Tissue Engineering MarketSegmentation Analysis

The Global Cell Therapy And Tissue Engineering Market is segmented on the basis of Material, Type, Application, And Geography.

Cell Therapy And Tissue Engineering Market, By Material

• Biologically Derived• Synthetic• Others

Based on Material, The market is segmented into Biologically Derived, Synthetic, and Others. For its efficiency over other natural origin derived materials, the Synthetic materials segment is projected to expand significantly. Synthetic materials are chosen over natural materials because they produce better results. Due to characteristics like biocompatibility, biodegradability, non-toxicity, good cell recognition properties, and ease of functionalization, biologically derived materials are aiding the Cell Therapy And Tissue Engineering Market growth.

Cell Therapy And Tissue Engineering Market, By Type

• Cell Therapy• Tissue Engineering• Others

Based on Type, The market is segmented into Cell Therapy, Tissue Engineering, and Others. The Cell Therapy segment has been dominating the market in the past, Owing to the expanding pipeline for therapies. The treatment using the Cell Therapy of the immune system and blood disorders for cancer patients has driven the growth of this segment. However, the tissue engineering segment is expected to witness significant growth during the forecast period. The innovative 3D-designed nano-fibers have proved to be an alternative to repair and regenerate damaged neurons. Such techniques have boosted the growth of tissue engineering products.

Cell Therapy And Tissue Engineering Market, By Application

• Genetic Diseases• Tissue Malignancy• Cell Defects• Neurodegenerative Disease• Others

Based on Application, The market is segmented into Genetic Diseases, Tissue Malignancy, Cell Defects, Neurodegenerative Disease, and Others. Due to the widespread use of stem cell therapies in organ transplants for the treatment of immune systems and blood abnormalities in cancer patients, the Cell Defects segment is projected to expand profitably during the forecast period. Furthermore, advances in technology and the use of advanced equipment have resulted in an increase in the application areas of neurodegenerative diseases. During the forecast period, this is expected to drive demand for this segment.

Cell Therapy And Tissue Engineering Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, The Global Cell Therapy And Tissue Engineering Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The presence of cutting-edge universities and research centers for Stem Cell Biology in the United States of America is a major factor driving the growth of cell therapy and tissue engineering in North America. Furthermore, significant funding from federal agencies for the growth of this industry is propelling the market. Because of the region’s growing awareness of tissue-engineered products, rising demand for innovative healthcare services in emerging markets, developing R&D sector, and increased presence of key players, Asia-Pacific introduces lucrative opportunities for players operating in the Cell Therapy And Tissue Engineering Market. Furthermore, the growing focus on regenerative medicine and the development of healthcare infrastructure has resulted in rapid market development.

Key players

The “Global Cell Therapy And Tissue Engineering Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as BioCardia Inc., Betalin Therapeutics Ltd., MEDIPOST Co., Ltd, MaxCyte Inc., BioReliance Corporation, AbbVie Inc., Integra Lifesciences, Becton, Dickinson, and Company, Zimmer Biomet, C. R. Bard, Organogenesis, Biotime Inc., B. Braun Melsungen AG, Bio Tissue Technologies, Osiris Therapeutics.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• April 2022 – Bonus BioGroup, a Haifa-based biotech company, recently finished a preclinical trial regarding the efficacy of its drug MesenCure, which is being formed for the treatment of serious COVID patients, in limiting life-threatening inflammatory overreaction seen in patients with cytokine release syndrome.

• April 2022 – Satellite Bio raises $110 million to fund the development of implantable tissue therapies.

• April 2022 – Essent biologics introduces human mesenchymal stromal cells derived from Wharton’s jelly to advance cell therapy research.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.